Spleen erythroid cells with the CD71+TER119+ phenotype from mice on day 21 of the tumor growth were immunosuppressive; they suppressed T-cell proliferation by 50% at a suppressor:effector ratio of 1:1. The gene discussed is TFRC; the disease is neoplasm.